Follow The Filings

SMID Smith-Midland

Smith-Midland earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — 0.79 —
Rev — $23.4M —

Insider trades

Open-market buys and sales by SMID's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SMID insider trades
  • $108K bought by 2 insiders
  • $22K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Ashley B Smith CEO
    Buy
    $9,805 1,275 shares at $7.69 +0.7% to stake
    Traded Dec 7, 2018 Filed Sep 4
    ↗
  2. Ashley B Smith CEO
    Buy
    $54K 2,000 shares at $26.87 +1.1% to stake
    Traded Sep 1 Filed Sep 4
    ↗
  3. Matthew I Smith Director
    Buy
    $54K 2,000 shares at $27.15 +20% to stake
    Traded Sep 2 Filed Sep 4
    ↗
  4. Richard Gerhardt Director
    Sale
    $22K 666 shares at $33.26 12% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 3.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 3.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.